-Rediff.com Today, Irom Sharmila, the Manipur civil rights activist, marks 12 years of her fast in protest against the Armed Forces Special Powers Act in the state. She remains in judicial custody where she continues to be force-fed through her nose. Deepti Priya Mehrotra, author of Burning Bright: Irom Sharmila and the Struggle for Peace in Manipur, recalls her association with the Iron Lady of Manipur. I met her initially in October 2006...

-The Business Standard The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of Drugs  The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits.  The move is aimed at...

-The Hindu Health sector outlay tripled to Rs.3-lakh crore Prime Minister Manmohan Singh said on Saturday that the allocation for the health sector during the 12th Plan had been increased three times over the previous Plan allotment to address complex challenges. The outlay in the 12th Plan had been fixed at Rs. 3-lakh crore, which was 1.95 per cent of the Gross Domestic Product. During the last Plan period, the sector had got...

-Live Mint While natural disasters grab our attention, everyday events like illness drag most people into poverty  In a small town of Gujarat, I met Chandibai, a woman, about 50 years of age. Fifteen years previously, her husband, Gokalji, had owned a general-purpose shop in the town centre. The family also owned a house and some agricultural land. In 1989, Gokalji developed an illness that confined him to bed, sometimes at home...

-The Hindu Drugs Controller must be told of adverse events within 24 hours Under sharp criticism for inadequate monitoring of clinical trials in the country, the Union Government is contemplating major changes in the Drugs & Cosmetics Act, 1940, and its Rules. These would make it mandatory for the Investigator to report all serious adverse events, including deaths, to the Drugs Controller General of India (DGCI), as well as the sponsor and...